The Biotech Investor

About The Biotech Investor

The Biotech Investor is a YouTube channel focused on financial analysis within the biotechnology sector. The channel, operating under the handle @thebiotechinvestor-mq9b, provides insights into emerging small to medium-sized biotech companies. Content frequently covers groundbreaking therapies and medications, along with detailed financial analyses of promising biotech stocks. With 61 videos published, the channel has accumulated 227,213 total views. The creator emphasizes the potential of these companies to impact healthcare and offers investment considerations. Based in the US, The Biotech Investor primarily operates within the finance category, with a secondary focus on health, aligning with its niche in biotech investment. The channel aims to inform a community of investors about developments in the dynamic biotechnology market.

The Biotech Investor's estimated sponsorship rates

The estimated rate for an integrated video on The Biotech Investor ranges from $80 to $134, with a typical rate of $98. This pricing is influenced by several factors, including the channel's audience size and its specific niche in biotech finance. The finance category generally commands a higher CPM band, estimated between $45 and $75, with an anchor CPM of $55. This elevated CPM reflects the specialized and high-value nature of financial content, particularly in a complex sector like biotechnology. Despite being classified in the nano audience tier with 11,300 subscribers, the channel's focus on a lucrative and engaged investment audience contributes to its rate structure. The estimate is based on a projected 1,785 views per video, derived from a subscriber fallback model due to the absence of recent average view data. The specific format of an integrated video, which involves a brand message woven into the content, also plays a role in the valuation. For a comprehensive understanding of the pricing methodology, refer to the /methodology page.

Who should partner with The Biotech Investor?

The Biotech Investor's audience comprises individuals interested in financial markets, specifically within the biotechnology and healthcare sectors. The content is tailored for savvy investors seeking insights into emerging small to medium-sized biotech companies and their potential for growth. This demographic is likely to engage with brands in categories such as fintech apps, online brokerages, personal-finance education platforms, and specialized investment research services. Given the channel's focus on detailed financial analysis of biotech stocks, its viewers are typically interested in long-term investment strategies and market trends. The channel's 11,300 subscribers, placing it in the nano audience tier, indicate a dedicated but smaller community. Peer channels in the finance niche, such as 미국 주식 리포트 (제인 CFA) and HYBRID Analytics, also cater to audiences with similar interests in stock analysis and investment strategies, suggesting a shared demographic profile across these specialized finance content creators.

The Biotech Investor's growth and performance

The Biotech Investor's subscriber growth data is currently limited. The channel was first tracked on 2026-05-29, at which point it had 11,300 subscribers. The latest snapshot, also taken on 2026-05-29, shows the same subscriber count. This provides a snapshot span of one day with no recorded change in subscriber numbers during this brief period. We do not yet have historical data to analyze long-term subscriber trends or significant growth spurts. Additionally, average view data for the last 30 days is not available, which limits the ability to assess recent content performance and audience engagement patterns. Further tracking will be necessary to establish a comprehensive growth trajectory for The Biotech Investor.

How our pricing estimate works for The Biotech Investor

The estimated rates for The Biotech Investor are generated through an algorithmic model that considers multiple data points. This model begins with the channel's subscriber count, which is then multiplied by a niche-specific CPM (Cost Per Mille, or cost per thousand views). For The Biotech Investor, the finance niche commands a CPM band of $45-75, with an anchor of $55, reflecting the value of this specialized audience. Platform and format multipliers are also applied to adjust for the specific characteristics of YouTube content and integrated video placements. The current estimate is based on a projected 1,785 views per video, derived from a subscriber fallback method due to the absence of recent average view data, resulting in a low confidence level for this specific view basis. The channel is categorized within the nano audience tier. For a detailed explanation of the variables, calculations, and confidence levels used in our algorithmic pricing, please refer to the full methodology document available at /methodology.